There has even been a documented case of a Schwannoma being induced from a neurofibroma due to radiation therapy. Medications
ACE inhibitors have been proposed as a novel treatment of neurofibromas. ACE inhibitors are currently used to treat hypertension and congestive heart failure, to avert remodeling and reinfarction after myocardial infarction, and to ameliorate diabetic nephropathy and other renal diseases. ACE inhibitors work by indirectly down regulating TGF-beta, which is a growth factor that has been shown to influence the development of tumors. No effect
Pirfenidone inhibits fibroblast growth. Studies showed no improvement over controls. Tipifarnib (also known as drug R115777) inhibits the activation of RAS. This drug is a Farnesyltransferase inhibitor which inhibits the Ras kinase in a post translational modification step before the kinase pathway becomes hyperactive. It successfully passed phase one clinical trials but was suspended (NCT00029354) in phase two after showing no improvement over controls. Research
The many drug therapies under study for neurofibromas are in various stages of research; more time will be required to determine if these are viable options for the treatment of neurofibromas.
In breastfeeding, lactation failure may refer to:

Primary lactation failure, a cause of low milk supply in breastfeeding mothers
Cessation of breastfeeding before the mother had planned to stop, usually as a result of breastfeeding difficulties
Low milk supply in generalLactation failure can result in neonatal jaundice. References

Lawrence, Ruth A. (1986). "Maternal Factors in Lactation Failure". Human Lactation 2. Boston, MA: Springer US. pp. 283–291. doi:10.1007/978-1-4615-7207-7_25. ISBN 978-1-4615-7209-1. Lawrence, Ruth (2016). Breastfeeding : a guide for the medical profession, 8th edition. Philadelphia, PA: Elsevier. p. 836. ISBN 978-0-323-35776-0. == External links ==